$APUS

$2.90 +$0.00 (0.17%) Close

$APUS Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 1.5M shares outstanding

Who owns APUS?

By type of holder

Institutions 28.3% Insiders 0.0% Everyone else 71.8%

Concentration Top 8 holders own 167.4%

Inscobee Inc. 139.1% · Hemenway Trust Co LLC 18.2%

Institutional ownership

28.3%

-1.5 pts vs last qtr

Institutional holders

+1 vs last qtr

Net shares bought

−22.5K

by institutions in Q2 2026

New / sold out

2 / 1

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Jane Street Group, LLC NEW +16.0K
UBS Group AG +7.6K

Biggest sellers in Q2 2026

Vanguard Capital Management LLC −32.3K
Two Sigma Securities, LLC SOLD OUT −10.6K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Apimeds Pharmaceuticals US Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2024–FY2025

+37.7%

+37.68% a year

Each share's claim on the business

−27.4%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $1.57M

over 2 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years0% 1–3 years0% Under 1 year100%

Quarterly turnover

8.1%

of institutional shares changed hands

Top 10 managers, median time held

3 quarters

Super Investors

Investment managers reporting APUS on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
HT Hemenway Trust Co LLC	274.0K	18.16%	Unchanged	Q3 '25	0.0%
Shares held by quarter Peak holding274.0K (Q4'25) Change over 8 quarters+274.0K Share of the company18.160% Hemenway Trust Co LLC's full portfolio →
VC Vanguard Capital Management LLC	63.7K	4.22%	−32.3K (−33.6%)	Q3 '25	0.0%
Shares held by quarter Peak holding95.9K (Q1'26) Change over 8 quarters+63.7K Share of the company4.220% Vanguard Capital Management LLC's full portfolio →

Hemenway Trust Co LLC

274.0K

% of company

18.16%

Change vs last qtr

Unchanged

Held since

Q3 '25

Vanguard Capital Management LLC

63.7K

% of company

4.22%

Change vs last qtr

−32.3K (−33.6%)

Held since

Q3 '25

6 more super investors behind a free account

See every manager holding Apimeds Pharmaceuticals US Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting APUS on Form N-PORT; together they hold 6.7% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
VE Vanguard Extended Market Index Fund Vanguard Index Funds	$46.5K	51.6K	3.42%	0.00%	June 30, 2026
FE Fidelity Extended Market Index Fund Fidelity Concord Street Trust	$38.5K	27.3K	1.81%	0.00%	May 31, 2026

Vanguard Extended Market Index Fund

Vanguard Index Funds

Position value

$46.5K

% of company

3.42%

% of the fund

0.00%

As of

June 30, 2026

Fidelity Extended Market Index Fund

Fidelity Concord Street Trust

Position value

$38.5K

% of company

1.81%

% of the fund

0.00%

As of

May 31, 2026

2 more funds behind a free account

See every fund holding Apimeds Pharmaceuticals US Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
I Inscobee Inc. 5%+ holder 13D · 16.7%	2.1M	139.14%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company139.140% Disclosed stake13D · 16.7% View the 13D/G filing →

Inscobee Inc.

5%+ holder13D · 16.7%

2.1M

% of company

139.14%

Change vs last qtr

—

Held since

—

Comments